0001182489-18-000381.txt : 20180905 0001182489-18-000381.hdr.sgml : 20180905 20180905182733 ACCESSION NUMBER: 0001182489-18-000381 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180831 FILED AS OF DATE: 20180905 DATE AS OF CHANGE: 20180905 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEANWELL CLIVE CENTRAL INDEX KEY: 0001204787 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-31191 FILM NUMBER: 181056299 MAIL ADDRESS: STREET 1: THE MEDICINES CO STREET 2: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDICINES CO /DE CENTRAL INDEX KEY: 0001113481 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043324394 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-290-6000 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: MEDICINES CO/ MA DATE OF NAME CHANGE: 20000504 4 1 edgar.xml FORM 4 - X0306 4 2018-08-31 0 0001113481 MEDICINES CO /DE MDCO 0001204787 MEANWELL CLIVE 8 SYLVAN WAY PARSIPPANY NJ 07054 1 1 0 0 CEO Common Stock 2018-08-31 4 A 0 375 28.28 A 352409 D Common Stock 2018-09-04 4 S 0 50000 39.31 D 302409 D Shares of common stock acquired pursuant to The Medicines Company Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period beginning March 1, 2018 and ending August 31, 2018. In accordance with the terms of the ESPP, these share were purchased based on 85% of the fair market value closing price of the issuer's common stock on March 1, 2018. Sales were effected pursuant to a Rule 10b5-1 program adopted by Dr. Meanwell. Dr. Meanwell's 10b5-1 program is terminated. Represents the weighted average sales price of the shares sold ranging from a low of $39.03 to a high of $39.77 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. /s/ Stephen M. Rodin, Attorney-in-Fact for Clive Meanwell 2018-09-05